U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012

NEW YORK, May 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012 http://www.reportlinker.com/p0170913/US-Market-for-Diabetes-Monitoring-Treatment-and-Drug-Delivery-2012.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The U.S. market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17.87 billion by 2018.

The market segments covered in this report include:

• traditional blood glucose meters,

• continuous glucose monitoring systems,

• blood glucose test strips,

• lancets and lancing devices,

• insulin,

• insulin syringes,

• insulin pens and

• insulin pumps

Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Market growth for diabetes diagnosis, treatment and drug delivery will be led by double-digit growth in the continuous glucose monitor, insulin pen and insulin pump segments.

Within the diabetes diagnosis, treatment and drug deliver market, companies such as Novo Nordisk, Sanofi, Eli Lilly and Lifescan lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios. This is an exective summary only, the full report is also available for purchase.

TABLE OF CONTENTS.......................................................................................................ILIST OF FIGURES.............................................................................................................VILIST OF CHARTS................................................................................................................XEXECUTIVE SUMMARY................................................................................................... 11.1 U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET.................. 11.2 GROWTH TRENDS BY SEGMENT ................................................................................... 21.3 BLOOD GLUCOSE MONITORING MARKET .................................................................... 31.4 INSULIN MARKET.......................................................................................................... 41.5 INSULIN SYRINGE MARKET .......................................................................................... 51.6 INSULIN PEN MARKET .................................................................................................. 61.7 INSULIN PUMP MARKET ............................................................................................... 71.8 COMPETITIVE ANALYSIS .............................................................................................. 8RESEARCH METHODOLOGY......................................................................................... 92.1 RESEARCH SCOPE ......................................................................................................... 92.2 IDATA'S 9-STEP METHODOLOGY ................................................................................. 9Step 1: Project Initiation & Team Selection .................................................................. 10Step 2: Prepare Data Systems and Perform Secondary Research................................. 12Step 3: Preparation for Interviews & Questionnaire Design ........................................ 13Step 4: Performing Primary Research........................................................................... 14Step 5: Research Analysis: Establishing Baseline Estimates ........................................ 16Step 6: Market Forecast and Analysis ........................................................................... 17Step 7: Identify Strategic Opportunities ........................................................................ 19Step 8: Final Review and Market Release ..................................................................... 20Step 9: Customer Feedback and Market Monitoring..................................................... 21Table of Contents© iData Research Inc., 2012 www.idataresearch.net iiU.S. DIABETES DIAGNOSIS, TREATEMENT AND DRUG DELIVERYMARKET............................................................................................................................ 223.1 INTRODUCTION ........................................................................................................... 223.1.1 Types of Diabetes.................................................................................................. 223.1.1.1 Type 1 Diabetes ...........................................................................................223.1.1.2 Type 2 Diabetes ...........................................................................................223.1.1.3 Gestational Diabetes ...................................................................................233.1.1.4 Prediabetes ..................................................................................................233.1.2 Diabetes Complications........................................................................................ 243.1.3 Risk Factors Associated with Type I and Type 2 Diabetes ................................... 263.1.4 Signs and Symptoms.............................................................................................. 283.1.5 Diabetes Monitoring ............................................................................................. 293.1.5.1 Initial Diagnosis ..........................................................................................293.1.5.2 Blood Glucose Monitoring Systems.............................................................303.1.5.3 Urinary Glucose Monitoring .......................................................................303.1.5.4 Noninvasive and Minimally Invasive Monitoring Devices ..........................313.1.6 Treatment.............................................................................................................. 323.1.6.1 Lifestyle Measures .......................................................................................323.1.6.2 Insulin ..........................................................................................................323.1.6.3 Oral Antidiabetic Drugs ..............................................................................323.1.6.4 Injectable Antidiabetic Drugs......................................................................333.1.7 Drug Delivery Systems.......................................................................................... 333.1.7.1 Insulin Syringes ...........................................................................................333.1.7.2 Insulin Pens .................................................................................................333.1.7.3 Insulin Pumps ..............................................................................................333.1.7.4 Inhaled Insulin.............................................................................................343.2MARKET OVERVIEW................................................................................................... 353.3 TREND ANALYSIS BY MARKET SEGMENT.................................................................. 403.4MARKET DRIVERS AND LIMITERS .............................................................................. 433.4.1 Market Drivers...................................................................................................... 433.4.2 Market Limiters..................................................................................................... 443.5 COMPETITIVE ANALYSIS ............................................................................................ 463.5.1 Market Concentration........................................................................................... 55Table of Contents© iData Research Inc., 2012 www.idataresearch.net iii3.6MERGERS AND ACQUISITIONS .................................................................................... 57TRADITIONAL BLOOD GLUCOSE METER MARKET............................................ 584.1 INTRODUCTION ........................................................................................................... 584.2MARKET OVERVIEW................................................................................................... 604.3MARKET ANALYSIS AND FORECAST .......................................................................... 654.3.1 Professional Blood Glucose Meter Market........................................................... 674.3.2 Personal Blood Glucose Meter Market ................................................................ 734.4MARKET DRIVERS AND LIMITERS .............................................................................. 764.4.1 Market Drivers...................................................................................................... 764.4.2 Market Limiters..................................................................................................... 774.5 COMPETITIVE ANALYSIS ............................................................................................ 79CONTINUOUS GLUCOSE MONITORING MARKET ................................................ 845.1 INTRODUCTION ........................................................................................................... 845.2MARKET OVERVIEW................................................................................................... 865.2.1 Total Continuous Glucose Monitoring Market..................................................... 865.2.2 Emerging Markets: Intravascular Continuous Glucose Monitoring.................... 865.3MARKET ANALYSIS AND FORECAST .......................................................................... 915.3.1 Total CGM Market................................................................................................ 915.4MARKET DRIVERS AND LIMITERS .............................................................................. 985.4.1 Market Drivers...................................................................................................... 985.4.2 Market Limiters..................................................................................................... 995.5 COMPETITIVE ANALYSIS .......................................................................................... 101BLOOD GLUCOSE TEST STRIP MARKET ............................................................... 1046.1 INTRODUCTION ......................................................................................................... 1046.2MARKET OVERVIEW................................................................................................. 1056.3MARKET ANALYSIS AND FORECAST ........................................................................ 1106.3.1 Professional Blood Glucose Test Strip Market................................................... 1136.3.2 Personal Blood Glucose Test Strip Market ........................................................ 1166.4MARKET DRIVERS AND LIMITERS ............................................................................ 1196.4.1 Market Drivers.................................................................................................... 1196.4.2 Market Limiters................................................................................................... 1206.5 COMPETITIVE ANALYSIS .......................................................................................... 121Table of Contents© iData Research Inc., 2012 www.idataresearch.net ivLANCET AND LANCING DEVICE MARKET............................................................ 1267.1 INTRODUCTION ......................................................................................................... 1267.2MARKET OVERVIEW................................................................................................. 1277.3MARKET ANALYSIS AND FORECAST ........................................................................ 1327.3.1 Professional Lancet and Lancing Device Market............................................... 1357.3.2 Personal Lancet and Lancing Device Market .................................................... 1387.4MARKET DRIVERS AND LIMITERS ............................................................................ 1417.4.1 Market Drivers.................................................................................................... 1417.4.2 Market Limiters................................................................................................... 1427.5 COMPETITIVE ANALYSIS .......................................................................................... 143INSULIN MARKET.......................................................................................................... 1478.1 INTRODUCTION ......................................................................................................... 1478.1.1 Insulin Types....................................................................................................... 1478.2MARKET OVERVIEW................................................................................................. 1518.3MARKET ANALYSIS AND FORECAST ........................................................................ 1568.4MARKET DRIVERS AND LIMITERS ............................................................................ 1668.4.1 Market Drivers.................................................................................................... 1668.4.2 Market Limiters................................................................................................... 1678.5 COMPETITIVE ANALYSIS .......................................................................................... 168INSULIN SYRINGE MARKET ...................................................................................... 1719.1 INTRODUCTION ......................................................................................................... 1719.2MARKET OVERVIEW................................................................................................. 1729.3MARKET ANALYSIS AND FORECAST ........................................................................ 1769.3.1 Professional Insulin Syringe Market .................................................................. 1799.3.2 Personal Insulin Syringe Market ........................................................................ 1829.4MARKET DRIVERS AND LIMITERS ............................................................................ 1859.4.1 Market Drivers.................................................................................................... 1859.4.2 Market Limiters................................................................................................... 1869.5 COMPETITIVE ANALYSIS .......................................................................................... 187INSULIN PEN MARKET................................................................................................. 19010.1 INTRODUCTION ....................................................................................................... 190Table of Contents© iData Research Inc., 2012 www.idataresearch.net v10.2MARKET ANALYSIS AND FORECAST ...................................................................... 19110.3MARKET DRIVERS AND LIMITERS .......................................................................... 19410.3.1 Market Drivers.................................................................................................. 19410.3.2 Market Limiters................................................................................................. 19510.4 COMPETITIVE ANALYSIS ........................................................................................ 196INSULIN PUMP MARKET............................................................................................. 19911.1 INTRODUCTION ....................................................................................................... 19911.2MARKET OVERVIEW............................................................................................... 20111.3MARKET ANALYSIS AND FORECAST ...................................................................... 20611.3.1 Total Traditional Insulin Pump Market............................................................ 20811.3.1.1 Traditional Pump Market ........................................................................21011.3.1.2 Infusion Set Market..................................................................................21311.3.2 Total Patch Pump Market................................................................................. 21511.3.2.1 Patch Pump Controller Market ...............................................................21711.3.2.2 Insulin Pod Market ..................................................................................22011.3.3 Simple Pump Market......................................................................................... 22311.4MARKET DRIVERS AND LIMITERS .......................................................................... 22611.4.1 Market Drivers.................................................................................................. 22611.4.2 Market Limiters................................................................................................. 22711.5 COMPETITIVE ANALYSIS ........................................................................................ 22911.5.1.1 Emerging Competitors.............................................................................231APPENDIX 1: EMERGING MARKETS & ALTERNATIVE THERAPIES............. 23412.1 ARTIFICIAL PANCREAS ........................................................................................... 23412.1.1 Mechanical Artificial Pancreas ........................................................................ 23412.1.2 Bio-Artificial Pancreas ..................................................................................... 23512.2 NEEDLESS INJECTORS ............................................................................................. 236ABBREVIATIONS............................................................................................................ 238

To order this report: In Vitro

Diagnostic Industry: U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery 2012

More  Market Research Report

Check our  Industry Analysis and Insights

Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker